-

FillPoint Health and US Heart & Vascular Partner to Expand Access to Innovative Therapies Across Complex Cardiovascular Disease Areas

DUBLIN, Ohio--(BUSINESS WIRE)--FillPoint Health, a URAC- and ACHC-accredited specialty pharmacy and management services organization (MSO) and a Lyceum Company, has announced the continued expansion of its strategic partnership with US Heart & Vascular (USHV) to advance patient access to innovative therapies across complex and underserved cardiovascular disease categories.

"This [partnership] will support clinicians, improve patient access, and bring greater consistency to how complex therapies are delivered across care settings.” - Michael Baldzicki, CRO of FillPoint Health

Share

This collaboration reflects a shared commitment to improving care for patients living with progressive cardiomyopathies, heart failure, and related cardiovascular conditions that require specialized treatment pathways, close monitoring, and high-touch coordination. Through the partnership, FillPoint Health will work closely with USHV’s national network of cardiovascular clinics to support disease states where timely access, coordinated care, and operational precision are critical to specialty pharmacy patient outcomes.

The partnership is designed to address some of the most challenging aspects of cardiovascular care, including advanced heart failure management, fluid overload and edema-related conditions, and rare or progressive cardiomyopathies by streamlining how therapies are accessed, coordinated, and delivered within provider practices. By aligning specialty pharmacy services, MSO infrastructure, and provider-centric workflows, FillPoint Health and USHV aim to create a scalable and repeatable care model that supports both established and emerging therapeutic areas within cardiology.

“At FillPoint Health, our focus is on enabling access to innovative therapies in complex cardiovascular disease categories where coordination and execution matter most,” said Michael Baldzicki, Chief Revenue Officer of FillPoint Health. “Partnering with USHV allows us to extend our pharmacy-led, provider-centric model into advanced cardiology care. This will support clinicians, improve patient access, and bring greater consistency to how complex therapies are delivered across care settings.”

From USHV’s perspective, the collaboration supports its mission to expand access to advanced care models across its national footprint. By working with FillPoint Health, USHV clinics benefit from a specialty pharmacy partner that understands the operational, financial, and compliance requirements necessary to support complex cardiovascular therapies across diverse patient populations.

This partnership underscores FillPoint Health’s broader strategy to expand beyond its foundational therapeutic areas while maintaining a disciplined, provider-focused approach to growth. By addressing unmet needs in advanced cardiology and heart-failure-related disease management, FillPoint Health and USHV are positioning themselves at the forefront of innovative, integrated cardiovascular care delivery.

About FillPoint Health

FillPoint Health, A Lyceum Company, is a provider-centric specialty pharmacy and management services organization (MSO) designed to support complex therapies through high-touch coordination, compliant program execution, and scalable operational infrastructure. As part of the Lyceum Health family of companies, FillPoint Health works alongside technology-enabled and service-driven platforms to help providers, patients, and pharmaceutical partners improve access, adherence, and outcomes across specialty disease states.

About US Heart & Vascular

US Heart & Vascular is a leading national cardiovascular physician practice management organization supporting cardiology and vascular practices across the United States. USHV partners with clinicians to deliver high-quality, patient-centered cardiovascular care while enabling access to innovative treatment approaches across a broad range of cardiovascular conditions.

Contacts

Media Contact:
Mike Baldzicki
CRO, Lyceum Health
FillPoint Health | A Lyceum Company
Email: info@fillpointhealth.com

FillPoint Health


Release Summary
The continued expansion of FillPoint Health & USHV partnership aims to expand a scalable care model that supports underserved areas in cardiology.
Release Versions

Contacts

Media Contact:
Mike Baldzicki
CRO, Lyceum Health
FillPoint Health | A Lyceum Company
Email: info@fillpointhealth.com

Social Media Profiles
More News From FillPoint Health

US Heart & Vascular, FillPoint Health, and Corstasis Therapeutics Announce Strategic Collaboration to Improve Heart Failure Care Through Enhanced Access to Enbumyst™ (bumetanide nasal spray)

DUBLIN, Ohio--(BUSINESS WIRE)--US Heart & Vascular (USHV), a leading national cardiovascular physician practice management organization, today announced a strategic collaboration with FillPoint Health, a Lyceum Company and URAC/ACHC-accredited Specialty Pharmacy and Management Services Organization (MSO), and Corstasis Therapeutics to improve access, adherence, and patient outcomes in the management of heart failure. Under this collaboration, FillPoint Health will serve as the preferred spe...

FillPoint Health Forms Collaborative Partnership with Noble, an Aptar Pharma Company, to Enhance Patient Experience and Drive Treatment Adherence

DUBLIN, Ohio--(BUSINESS WIRE)--FillPoint Health, a Lyceum Health company and URAC/ACHC-accredited specialty pharmacy and MSO, announced today a strategic partnership with Noble, an Aptar Pharma company and global leader in drug delivery training and onboarding solutions. This collaboration aims to enhance the patient experience through provider engagement and pharmaceutical partnerships, ensuring proper device use, improved adherence, and better clinical outcomes. Under this partnership, FillPo...

FillPoint Health, a Lyceum Health Company, Announces Exclusive Specialty Pharmacy Partnership with US Heart & Vascular

DUBLIN, Ohio--(BUSINESS WIRE)--FillPoint Health, a leading specialty pharmacy and MSO platform under Lyceum Health, is proud to announce an exclusive partnership with US Heart & Vascular (USHV), the nation’s premier cardiovascular management services organization, to streamline access, dispensing, and patient support services for innovative RNA interference (RNAi) therapies for rare, inherited disorders in cardiovascular disease. This collaboration marks a significant step in enhancing the...
Back to Newsroom